2021 Annual Meeting Shoulder Access Pass-From the Bench to the Operating Room: Optimizing Rotator Cuff Healing in 2021

From the Bench to the Operating Room: Optimizing Rotator Cuff Healing in 2021

Video Transcription

Video Summary

The talk addresses the controversial role of biology in improving rotator cuff surgery outcomes, focusing on PRP, scaffolds, and cellular therapy. While PRP shows no functional outcome improvement but may reduce re-tear rates, cellular therapies like bone marrow concentrate (BMAC) placed at the tendon-bone interface show promise in lowering re-tears. Scaffold use, including human allografts and xenografts, remains debated due to complications and uncertain biology integration. Combining scaffolds with biologics has yielded mixed results, possibly due to patient factors and biology placement. The future may lie in biologic grafts that support cell growth, but further human studies are needed.

Asset Caption

Dr. Jason Dragoo

Keywords

rotator cuff surgery

platelet-rich plasma (PRP)

cellular therapy

scaffolds

biologic grafts